Medicure annual gross margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Medicure's gross margin was 40.71% for fiscal 2025.
View full Medicure company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 40.71% | −19.03 pp |
| 2024 | 2024-12-31 | 59.75% | −4.74 pp |
| 2023 | 2023-12-31 | 64.48% | −5.21 pp |
| 2022 | 2022-12-31 | 69.69% | +11.23 pp |
| 2021 | 2021-12-31 | 58.46% | +14.28 pp |
| 2020 | 2020-12-31 | 44.19% | −19.77 pp |
| 2019 | 2019-12-31 | 63.95% | −21.78 pp |
| 2018 | 2018-12-31 | 85.74% | −1.49 pp |
| 2017 | 2017-12-31 | 87.23% | −0.07 pp |
| 2016 | 2016-12-31 | 87.30% | −2.46 pp |
| 2015 | 2015-12-31 | 89.77% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 43.06% | −8.45 pp |
| Q1 2026 | 2026-03-31 | 44.31% | −7.54 pp |
| Q4 2025 | 2025-12-31 | 31.57% | — |
| Q3 2025 | 2025-09-30 | 33.99% | — |
| Q2 2025 | 2025-06-30 | 51.51% | — |
| Q1 2025 | 2025-03-31 | 51.84% | −16.60 pp |
| Q1 2024 | 2024-03-31 | 68.44% | — |
Over the last five fiscal years, Medicure's gross margin decreased from 44.19% to 40.71%, a change of −3.47 percentage points. The latest reported quarter, Q2 2026, shows 43.06%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicure source filings ↗